MedPath

CIRCASSIA LIMITED

🇧🇸The Bahamas
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

49

Active:13
Completed:35

Trial Phases

4 Phases

Phase 1:12
Phase 2:18
Phase 3:2
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (33 trials with phase data)• Click on a phase to view related trials

Phase 2
18 (54.5%)
Phase 1
12 (36.4%)
Phase 3
2 (6.1%)
Not Applicable
1 (3.0%)

Efficacy and Safety of Grass-SPIRE Registration Study

Phase 2
Withdrawn
Conditions
Conjunctivitis
Rhinitis
Interventions
Drug: Placebo
First Posted Date
2016-06-10
Last Posted Date
2016-06-23
Lead Sponsor
Circassia Limited
Registration Number
NCT02795273
Locations
🇺🇸

Bernstein Clinical Research Center, LLC, Cincinnati, Ohio, United States

Birch-SPIRE Safety and Efficacy Study

Phase 2
Completed
Conditions
Rhinitis
First Posted Date
2015-06-23
Last Posted Date
2016-11-08
Lead Sponsor
Circassia Limited
Target Recruit Count
64
Registration Number
NCT02478060
Locations
🇨🇦

Centre de Recherche Appliqué en Allergie de Québec, Quebec, Canada

Ragweed-SPIRE Follow-On Study

Completed
Conditions
Rhinoconjunctivitis
Ragweed Allergy
First Posted Date
2015-03-24
Last Posted Date
2016-03-23
Lead Sponsor
Circassia Limited
Target Recruit Count
249
Registration Number
NCT02396680
Locations
🇨🇦

Kanata Allergy Services, Kanata, Ontario, Canada

🇨🇦

Inflamax Research, Mississauga, Ontario, Canada

🇨🇦

Windsor Allergy Asthma Associates, Windsor, Ontario, Canada

ToleroMune Grass Follow on Study

Completed
Conditions
Grass Allergy
Rhinoconjunctivitis
First Posted Date
2014-11-17
Last Posted Date
2014-11-17
Lead Sponsor
Circassia Limited
Target Recruit Count
84
Registration Number
NCT02292875

Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma

Phase 2
Completed
Conditions
Seasonal Allergic Rhinitis
Asthma
First Posted Date
2014-06-11
Last Posted Date
2015-03-24
Lead Sponsor
Circassia Limited
Target Recruit Count
54
Registration Number
NCT02161107
Locations
🇨🇦

Kingston General Hospital, Kingston, Ontario, Canada

🇨🇦

Cheema Research Inc, Mississauga, Ontario, Canada

🇨🇦

Inflamax Research, Mississauga, Ontario, Canada

and more 2 locations
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.